The annual congress of the European Society of Cardiology (ESC), the world’s largest congress on cardiovascular diseases, will take place on August 27-30 in full digital.
This event, dedicated to the prevention and treatment of cardiovascular risks and disease, will bring together – for the second consecutive year in a digital format – cardiologists, physicians, researchers, caregivers, pharmaceutical industries, and other scientific experts from around the globe, to discuss the latest developments and news in this therapeutic area.
Servier has been a major partner of the ESC for several years and will be present again this year with:
Following the congress, and throughout the month of September, Servier will launch, in partnership with the International Society of Hypertension, a new edition of its global public awareness campaign Because I Say So, #Takeyourmedicine focused on the importance of adherence to antihypertensive treatment.
Cardiovascular diseases are still the world’s leading causes of death. Committed for over 60 years to the treatment of these conditions, Servier is renowned for its knowledge and expertise. The Group is the 3rd largest pharmaceutical company in the world committed to the fight against cardiovascular disease*. Around the world, 22.2 million patients are treated with a Servier-branded drug for a condition affecting their heart or circulatory system.
* IQVA, Analytics Link – MAT Q1 2021